Learn more

SIGMA ALDRICH CO LLC

Overview
  • Total Patents
    340
  • GoodIP Patent Rank
    6,984
  • Filing trend
    ⇧ 108.0%
About

SIGMA ALDRICH CO LLC has a total of 340 patent applications. It increased the IP activity by 108.0%. Its first patent ever was published in 1998. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, foods and drinks and pharmaceuticals are SIGMA-ALDRICH CO LLC, LARGE SCALE BIOLOGY CORP and JP MINISTRY OF AGRICULTURE FOR.

Patent filings per year

Chart showing SIGMA ALDRICH CO LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Chen Fuqiang 80
#2 Davis Gregory D 66
#3 Kayser Kevin 35
#4 Mascarenhas Joaquina 26
#5 Odedra Rajesh 24
#6 Borgschulte Trissa 23
#7 Kreader Carol 22
#8 Ward Brian 22
#9 Lin Nan 21
#10 Ji Qingzhou 19

Latest patents

Publication Filing date Title
US2021095273A1 Modulation of microbiota compositions using targeted nucleases
WO2020243345A1 Monodispersed nanocarbons prepared from polysulfonated nanopolymers
WO2020215077A2 Stable targeted integration
WO2020210420A1 Accelerated polymerase chain reaction based on thermocycling enabled by millimeter wave heating
US2020263155A1 CRISPR/Cas fusion proteins and systems
SG11202101382VA Down-regulation of the cytosolic dna sensor pathway
US2021122773A1 Heteroatomic-based hole-transport materials
WO2019226347A1 Quantitative analysis of proteins
WO2019213528A1 Producing recombinant proteins with reduced levels of host cell proteins
EP3788151A1 Engineered cells with modified host cell protein profiles
EP3775213A1 Modification of immune-related genomic loci using paired crispr nickase ribonucleoproteins
AU2019222568A1 Engineered Cas9 systems for eukaryotic genome modification
US2019202856A1 Engineered crispr proteins for covalent tagging nucleic acids
CN111465655A Poloxamer compositions and methods of making and using same
US2019078126A1 Polymerase-mediated, template-independent polynucleotide synthesis
CN111295242A Improved HLB copolymers
CN111356530A Multi-needle solid phase micro-extraction device
US2019032053A1 Synthetic guide rna for crispr/cas activator systems
AU2018299995A1 Using nucleosome interacting protein domains to enhance targeted genome modification
EP3619728A1 Methods for making graphene oxide gels